Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Medical Science Monitor

• Publication date

  2009-01-29

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 19179972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Treatment of Rats with Haloperidol: Lack of an Effect on Brain N-Acetyl Aspartate Levels

  2006cited by this paper
• Gray matter abnormalities associated with duration of untreated psychosis.

  2006cited by this paper
• N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration.

  2005cited by this paper
• Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

  2005cited by this paper
• Sex differences in N-acetylaspartate correlates of general intelligence: An 1H-MRS study of normal human brain

  2005cited by this paper
• Measurement of Brain Metabolites by 1H Magnetic Resonance Spectroscopy in Patients with Schizophrenia: A Systematic Review and Meta-Analysis

  2005cited by this paper
• Hippocampus volume and treatment delays in first-episode schizophrenia.

  2005cited by this paper
• Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.

  2005cited by this paper
• The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).

  2005cited by this paper
• Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.

  2004cited by this paper
• The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia.

  2004cited by this paper
• Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.

  2004cited by this paper
• Correlates of cognitive deficits in first episode schizophrenia.

  2004cited by this paper
• Chlorpromazine equivalent doses for the newer atypical antipsychotics.

  2003cited by this paper
• Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia.

  2003cited by this paper
• Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.

  2003cited by this paper
• Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

  2003cited by this paper
• The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia.

  2003cited by this paper
• Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia.

  2003cited by this paper
• Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia.

  2002cited by this paper
• Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.

  2002cited by this paper
• Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.

  2002cited by this paper
• The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.

  2001cited by this paper
• Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.

  2001cited by this paper
• Causes and consequences of duration of untreated psychosis in schizophrenia.

  2000cited by this paper
• Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo

  2000cited by this paper
• Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia.

  2000cited by this paper
• Features of structural brain abnormality detected in first-episode psychosis.

  2000cited by this paper
• Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

  2000cited by this paper
• Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

  2000cited by this paper
• Proton Magnetic Resonance Spectroscopy in the Frontal and Temporal Lobes of Neuroleptic Naive Patients with Schizophrenia

  1999cited by this paper
• A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

  1999cited by this paper
• Defining the course of brain structural change and plasticity in schizophrenia.

  1999cited by this paper
• West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis.

  1999cited by this paper
• Duration of untreated psychosis and 12‐month outcome in first‐episode psychosis: the impact of treatment approach

  1999cited by this paper
• Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?

  1999cited by this paper
• Progressive atrophy of the frontal lobes in first‐episode schizophrenia: interaction with clinical course and neuroleptic treatment

  1999cited by this paper
• "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?

  1998cited by this paper
• Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?

  1998cited by this paper
• First-episode schizophrenia with long duration of untreated psychosis: Pathways to care

  1998cited by this paper
• Reproducibility of Proton Magnetic Resonance Spectroscopic Imaging in Patients with Schizophrenia

  1998cited by this paper
• Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

  1998cited by this paper
• Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

  1997cited by this paper
• The prodromal phase of first-episode psychosis: past and current conceptualizations.

  1996cited by this paper
• An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.

  1996cited by this paper
• Assessing Depression in Schizophrenia: The Calgary Depression Scale

  1993cited by this paper
• Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro

  1992cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper

• Hippocampal subfield activity in schizophrenia: Effects of the disease course.

  2025cites this paper
• Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status

  2023cites this paper
• Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis

  2023cites this paper
• The neurobiology of duration of untreated psychosis: a comprehensive review

  2022cites this paper
• Glutamate and N-Acetylaspartate Alterations Observed in Early Phase Psychosis: A Systematic Review of Proton Magnetic Resonance Spectroscopy Studies.

  2022cites this paper
• Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies

  2021cites this paper
• Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies

  2021cites this paper
• Alterations of neurometabolism in the dorsolateral prefrontal cortex and thalamus in transition to psychosis patients change under treatment as usual - A two years follow-up 1H/31P-MR-spectroscopy study.

  2021cites this paper
• Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level

  2021cites this paper
• Frontal neural metabolite changes in schizophrenia and their association with cognitive control: A systematic review

  2021cites this paper
• Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis.

  2019cites this paper
• Influence of muscarinic M1 receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study.

  2019cites this paper
• Antioxidant defense in schizophrenia and bipolar disorder: A meta‐analysis of MRS studies of anterior cingulate glutathione

  2019cites this paper
• Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis

  2018cites this paper
• Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)

  2018cites this paper
• Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia

  2018cites this paper
• Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study

  2018cites this paper
• Mechanisms underlying executive function deficits

  2017influential citation
• A review of altered biochemistry in the anterior cingulate cortex of first-episode psychosis

  2017cites this paper
• Combination of behaviorally sub‐effective doses of glutamate NMDA and dopamine D1 receptor antagonists impairs executive function

  2017cites this paper
• 1H-magnetic resonance spectroscopy in first episode and chronic schizophrenia patients.

  2016cites this paper
• Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.

  2016cites this paper
• Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4Tesla (1)H-MRS study.

  2016cites this paper
• Glutamate and dopamine in schizophrenia: An update for the 21st century

  2015cites this paper
• N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients

  2015cites this paper
• 1 Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia – A Systematic Review and Meta-Analysis

  2015cites this paper
• Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study.

  2014cites this paper
• Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

  2014cites this paper
• Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies

  2014influential citation
• The neurobiology and treatment of first-episode schizophrenia

  2014cites this paper
• NPAS3 variants in schizophrenia: a neuroimaging study

  2014cites this paper
• Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia

  2014cites this paper
• Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.

  2014influential citation
• T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

  2013cites this paper
• 3‐T proton magnetic spectroscopy in unmedicated first episode psychosis: A focus on creatine

  2013cites this paper
• Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use

  2013cites this paper
• Medial Prefrontal Cortex Neurochemical Metabolites in Schizophrenia and Schizoaffective Disorder: A Proton Magnetic Resonance Spectroscopy Study

  2013cites this paper
• Proton magnetic resonance spectroscopy changes after antipsychotic treatment.

  2013cites this paper
• Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia

  2013cites this paper
• Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

  2013cites this paper
• Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first‐episode treatment‐naïve schizophrenia patients

  2012cites this paper
• The glutamate hypothesis of schizophrenia: neuroimaging and drug development.

  2012cites this paper
• A 1H-MRS and Neurocognitive Analysis of Psychotic Symptoms in Stimulant Dependence

  2012cites this paper
• Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

  2012cites this paper
• Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia—A Systematic Review and

  2011cites this paper
• MR spectroscopy in schizophrenia

  2011cites this paper
• Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia—A Systematic Review and Meta-Analysis

  2011cites this paper
• Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia

  2011cites this paper
• Genetics in Psychiatry - up-to-date review 2011.

  2011cites this paper
• Protective effects of aqueous fruit extract from Sea Buckthorn (Hippophae rhamnoides L. Spp. Turkestanica) on haloperidol-induced orofacial dyskinesia and neuronal alterations in the striatum.

  2010cites this paper
• GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression

  2010cites this paper
• 1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage

  2009influential citation